Abstract:Bacterial coinfections in patients with COVID-19 are rare; however, coinfection with Staphylococcus (S.) aureus is relatively common. No detailed report of patients with COVID-19 and methicillin-resistant S. aureus (MRSA) coinfection has been documented. Herein, we present a case of a patient with COVID-19 and MRSA coinfection who developed MRSA empyema after pneumonia and bacteremia. A 59-year-old man was admitted to the intensive care unit for treatment of COVID-19 and bacterial pneumonia with septic shock. He was initially treated with antibiotics, antiviral agents, and steroids. On the third day of admission, MRSA was detected in both sputum and blood cultures. Although he was treated with appropriate vancomycin doses with monitoring of renal function and serum vancomycin concentrations, he developed bilateral pleural effusions one week after starting treatment. Initially, the bilateral pleural effusions were thought to have been caused by hypoalbuminemia. However, bilateral chest drainage was performed due to the onset of left-sided chest pain. The left-sided pleural effusion was exudative, whereas the right-sided pleural effusion was transudative. MRSA was later detected on culture of the left-sided effusion but not the right-sided effusion. Based on the findings of the pleural fluid examination, the patient was diagnosed with left-sided empyema. His symptoms and radiographic findings improved after a repeat drainage of the left pleural effusion. Vancomycin was administered for 28 days, and the patient was discharged on the twenty-eighth day of admission. These findings highlight the importance of pleural fluid examination for the prompt diagnosis of pleural infection. Early diagnosis of empyema and prompt chest drainage may help avoid the need for surgery. This report could contribute to the clinical management of patients with COVID-19 and MRSA coinfection.

S2557 The Conundrum of MRSA Cholecystitis and Cholestatic Liver Enzyme Elevation

Unraveling the Puzzle: The Secret Hideout of Methicillin-Resistant Staphylococcus aureus

An Unusual Presentation of Monofocal Methicillin-Resistant Staphylococcus aureus Hepatic Abscess in an Otherwise Healthy Man

S2430 Pyogenic Hepatic Abscesses Secondary to Ascending Cholangitis 13 Years Post-Cholecystectomy: A Case Report

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations

A COMPLEX CASE OF EMPHYSEMATOUS CHOLECYSTITIS IN AN ELDERLY PATIENT: DIAGNOSIS AND MANAGEMENT

Double trouble: an unusual case of Klebsiella pneumoniae invasive syndrome with liver abscess, gallbladder empyema and infective endocarditis

From Gut to Heart: A Case Report of Infectious Endocarditis Stemming From Cholecystitis-Induced Enterococcus faecium Bacteremia

Quadruple Complication in a Patient With Liver Cirrhosis: A Diagnostic Conundrum

Acute severe cholecystitis with empyema presenting as a gallbladder mass, jaundice and Mirizzi Syndrome: A case report

Pathogenic Bacteria Associated with Cholecystitis: A Review Article

Updates on Antibiotic Regimens in Acute Cholecystitis

Surgical Management of Cholecystitis with Chronic Perforation and Liver Abscess Associated with Choledocholithiasis

A Case of COVID-19 and Methicillin-Resistant Staphylococcus aureus (MRSA) Coinfection Resulting in MRSA Empyema

Acute cholangitis: a state-of-the-art review

[Sepsis caused by methicillin-resistant Staphylococcus aureus: the shadow of a persistent threat]

Essay: Methicillin-Resistant Staphylococcus aureus (MRSA)

Acute cholangitis with Achromobacter xylosoxidans bacteremia after endoscopic retrograde cholangiopancreatography in hilar cholangiocarcinoma: A case report

Preoperative Biliary MRSA Infection in Patients Undergoing Hepatobiliary Resection with Cholangiojejunostomy: Incidence, Antibiotic Treatment, and Surgical Outcome

S2600 Emphysematous Cholecystitis Secondary to Clostridium perfringens

S3484 Acute Esophageal Necrosis: A Rare Case With an Unusual Challenge